|
|
|
Volumn 7, Issue 4 Pt 1, 2003, Pages 425-436
|
|
Antenatal and neonatal antiretroviral therapy in HIV-infected women and their infants: a review of safety issues.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
EFAVIRENZ;
OXAZINE DERIVATIVE;
PROTEINASE INHIBITOR;
ZIDOVUDINE;
ADULT;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
CONGENITAL MALFORMATION;
DISEASE TRANSMISSION;
DISORDERS OF MITOCHONDRIAL FUNCTIONS;
DRUG COMBINATION;
FEMALE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
NEWBORN;
PREGNANCY;
PREGNANCY COMPLICATION;
PREGNANCY OUTCOME;
PREMATURITY;
PRENATAL EXPOSURE;
REVIEW;
ABNORMALITIES;
ADULT;
ANTI-HIV AGENTS;
CLINICAL TRIALS;
DISEASE TRANSMISSION, VERTICAL;
DRUG THERAPY, COMBINATION;
FEMALE;
HIV INFECTIONS;
HIV PROTEASE INHIBITORS;
HUMANS;
INFANT, NEWBORN;
INFANT, PREMATURE;
MITOCHONDRIAL DISEASES;
OXAZINES;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
PREGNANCY OUTCOME;
PRENATAL EXPOSURE DELAYED EFFECTS;
ZIDOVUDINE;
|
|
EID: 3142518242
PISSN: 1428345X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (7)
|
|
References (61)
|
